- Home
- BNTC vs NCV Comparison
BNTC vs NCV Comparison
Compare BNTC & NCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTC
- NCV
- Stock Information
- Founded
- BNTC 1995
- NCV 2003
- Country
- BNTC United States
- NCV United States
- Employees
- BNTC N/A
- NCV N/A
- Industry
- BNTC Biotechnology: Pharmaceutical Preparations
- NCV Finance Companies
- Sector
- BNTC Health Care
- NCV Finance
- Exchange
- BNTC Nasdaq
- NCV Nasdaq
- Market Cap
- BNTC 339.8M
- NCV 299.1M
- IPO Year
- BNTC N/A
- NCV N/A
- Fundamental
- Price
- BNTC $15.52
- NCV $13.02
- Analyst Decision
- BNTC Strong Buy
- NCV
- Analyst Count
- BNTC 7
- NCV 0
- Target Price
- BNTC $24.43
- NCV N/A
- AVG Volume (30 Days)
- BNTC 35.8K
- NCV 405.1K
- Earning Date
- BNTC 05-12-2025
- NCV 01-01-0001
- Dividend Yield
- BNTC N/A
- NCV 12.48%
- EPS Growth
- BNTC N/A
- NCV N/A
- EPS
- BNTC N/A
- NCV N/A
- Revenue
- BNTC N/A
- NCV N/A
- Revenue This Year
- BNTC N/A
- NCV N/A
- Revenue Next Year
- BNTC N/A
- NCV N/A
- P/E Ratio
- BNTC N/A
- NCV N/A
- Revenue Growth
- BNTC N/A
- NCV N/A
- 52 Week Low
- BNTC $4.75
- NCV $2.84
- 52 Week High
- BNTC $15.97
- NCV $3.59
- Technical
- Relative Strength Index (RSI)
- BNTC 72.92
- NCV 34.74
- Support Level
- BNTC $11.99
- NCV $12.70
- Resistance Level
- BNTC $15.97
- NCV $13.11
- Average True Range (ATR)
- BNTC 1.01
- NCV 0.22
- MACD
- BNTC 0.35
- NCV -0.03
- Stochastic Oscillator
- BNTC 91.04
- NCV 27.83
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
About NCV Virtus Convertible & Income Fund of Beneficial Interest
Virtus Convertible & Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. It intends to achieve the objective by investing in a portfolio of domestic convertible securities and non-convertible income-producing securities. Its portfolio of investments includes Software, the Internet, the Commercial Services sector in the form of Convertible Bonds and Notes, and Media, Oil, Gas & Consumable Fuels, and Entertainment sector in the form of Corporate Bonds and Notes.